News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,055 Results
Type
Article (39151)
Company Profile (283)
Press Release (648621)
Section
Business (203902)
Career Advice (1996)
Deals (35372)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16100)
Job Trends (14808)
News (344646)
Policy (32450)
Tag
Academia (2530)
Alliances (49187)
Alzheimer's disease (1262)
Approvals (16062)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (190)
Cancer (1377)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (282)
Clinical research (64712)
Collaboration (485)
Compensation (264)
COVID-19 (2542)
C-suite (109)
Data (1395)
Diabetes (177)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110020)
Executive appointments (397)
FDA (16787)
Funding (433)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2635)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16346)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7864)
Lung cancer (198)
Manufacturing (207)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19197)
Metabolic disorders (461)
Neuroscience (1585)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1703)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (121)
People (56464)
Phase I (20129)
Phase II (28499)
Phase III (21242)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5891)
Regulatory (21682)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1471)
Startups (3562)
United States (15255)
Vaccines (564)
Weight loss (182)
Date
Today (2)
Last 7 days (319)
Last 30 days (2195)
Last 365 days (35258)
2024 (35162)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37281)
Australia (6087)
California (3836)
Canada (1461)
China (310)
Colorado (173)
Connecticut (178)
Europe (79838)
Florida (538)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (635)
Massachusetts (2977)
Michigan (175)
Minnesota (292)
New Jersey (1108)
New York (1094)
North Carolina (743)
Northern California (1703)
Ohio (146)
Pennsylvania (930)
South America (1092)
Southern California (1471)
Texas (555)
Utah (108)
Washington State (401)
688,055 Results for "innoviva inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innoviva to Participate in the Citi 2024 Global Healthcare Conference
November 26, 2024
·
1 min read
Business
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”) today reported financial results for the first quarter ended March 31, 2024, and highlighted select corporate achievements.
May 8, 2024
·
11 min read
Biotech Bay
Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Innoviva, Inc., a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics, and a portfolio of strategic investments in healthcare assets, announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on Monday, June 10, 2024 at 1:20 p.m. Eastern Time.
June 3, 2024
·
2 min read
Press Releases
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States
December 16, 2024
·
6 min read
Biotech Bay
Innoviva to Participate in the BofA Securities Health Care Conference 2024
Innoviva, Inc., a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics, and a portfolio of strategic investments in healthcare assets, announced that Pavel Raifeld, Chief Executive Officer, will present at the BofA Securities Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024 at 9:20 a.m.
May 8, 2024
·
2 min read
Press Releases
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)
December 16, 2024
·
6 min read
Business
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”) today announced that it has entered into a secured credit agreement with Innoviva Strategic Opportunities LLC, a wholly-owned subsidiary of Innoviva, Inc. (Nasdaq: INVA) (collectively, “Innoviva”), Armata’s largest shareholder.
March 4, 2024
·
4 min read
Press Releases
Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
November 7, 2024
·
11 min read
Drug Development
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development Partnership at the European Society of Clinical Microbiology and Infectious Disease Global Congress taking place April 27-30, 2024, in Barcelona, Spain.
April 24, 2024
·
14 min read
Business
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2023 and highlighted select corporate achievements.
February 29, 2024
·
12 min read
1 of 68,806
Next